Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Cigna Group (CI)

NYSE: CI · Healthcare Plans · Bloomfield, CT

Our rating: Positive

Positive reaffirmed at $293.59, moderate conviction, November 6, 2026.

Breaks if: The Positive call is invalidated if free cash flow falls below $7.5 billion on a trailing twelve-month basis at any point in the next four quarterly reports, or if management sets FY2027 diluted EPS guidance more than 15% below the current year's reported $22.18 — either would signal that the thin operating margin is absorbing a cost or regulatory shock the present valuation no longer discounts.

Key figures

Market value$71.4B
Revenue, last 12 months$286.3B
Net income, last 12 months$6.0B
Free cash flow, last 12 monthsn/a
Price to earnings11.9×
Free cash flow yieldn/a
Dividend yield2.3%
Operating margin3.4%
Return on equity14.1%
Beta to the S&P 5000.15
Volatility, annualized29.9%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$73.7B5.6%$5.47n/a
June 30, 2026$71.7B6.7%$6.29n/a
March 31, 2026$68.5B4.6%$6.26n/a
December 31, 2025$72.5B10.4%$4.66n/a
September 30, 2025$69.7B9.5%$6.98n/a
June 30, 2025$67.2B11.0%$5.71n/a
March 31, 2025$65.5B14.4%$4.85n/a
December 31, 2024$65.6B28.4%$5.07n/a

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

15 ledger entries and 34 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.